Microbot Medical Inc. has entered into an At-the-Market Offering Agreement allowing it to sell up to $4,819,905 of its common stock, and has issued 4,276,486 shares for total gross proceeds of $4,819,278 before fees; the company holds a portfolio of 16 patents and 59 pending applications.